Biologit, an ADAPT Trinity College Dublin spin-in, recently featured in Silicon Republic via an interview with co-founder and immunologist by background, Dr Nicole Baker.
With the vast amount of medical literature available it can prove difficult for medical professionals to successfully keep abreast of the most up to date material. Using artificial intelligence, Biologet is focussed on creating a solution that will make medical care safer for patients and increase the efficiency of research in the field of pharmacovigilance.
Biologit is an AI enabled scientific literature monitoring platform co-founded by Dr Nicole Baker and Dr Bruno Ohana, tech expert specialised in the field of pharmacovigilance. The platform is designed for human and veterinary pharmacovigilance, meteriovigilance, cosmetovigilance and nutrivigilance. Since being founded in 2021, the platform has been helping companies automate the monitoring of scientific literature to great success.
Speaking on the project, co-founder Nicole Baker said:
“At Biologit, we specialise in cutting-edge active safety surveillance solutions across the life sciences spectrum. We do that by combining expert domain knowledge with the latest technology to build solutions that help keep patients safe,” she explains.
Biologit is a spin-in to the ADAPT Centre, funded by Enterprise Ireland under its Commercialisation Fund program, and headed up by Professor Lucy Hederman in Trinity College Dublin. This commercialisation project is run jointly by Dr Nicole Baker and Dr Bruno Ohana.
Read the full article here.
